Science | Page 19 of 29

The Loop Has Closed: The Artificial Pancreas Program Comes to Life in Israel

Diabetes technology has vastly improved in the last decade, and most people with diabetes who have the opportunity to wear an insulin pump or a continuous glucose monitor are grateful for the assistance they provide. But even with these advanced tools, the biggest burdens of diabetes - the insulin dosing and blood sugar testing - still lie on the person with diabetes or a caregiver.

A Whirlwind Tour: TEDxDelMar on a Type 1 Diabetes Cure, Part 1

A recurring theme in many of the talks: type 1 diabetes is becoming more and more prevalent every year, especially in children under the age of five...

Diabetes and Stem Cell Research: A Report From The World Stem Cell Summit

Stem cells and diabetes are old friends, and if you’ve spent any time reading about diabetes, you probably have at least a vague sense that…

Lung Disease Drug May Stop Progression of Type 1 Diabetes

Studies show Glassia can delay the progression of type 1 diabetes and stop the destruction of beta cells...

TEDx Ticket Giveaway!

The top names in diabetes research will be at TEDxDelMar in San Diego, discussing the future of diabetes care and cure. Want to be there? ASweetLife, in conjunction with the organizing committee of the event, is giving away 10 free tickets to TEDxDelMar! So if you can be in San Diego on October 15, 2011 and would like to attend, send an email to TEDx@asweetlife.org, and we'll enter you in a drawing.

Who is the Largest Single Funder of Diabetes Research in the U.S.?

In 2010, the NIDDK allocated a whopping $640,444,000 to projects in diabetes, endocrinology, and metabolic diseases.The ADA’s research funding in 2010 was $33.5 million...

TEDxDelMar: Preventing and Curing Type 1 Diabetes

On October 15th, we will have TEDxDelMar, with seventeen amazing speakers, all talking about what's next in type 1 diabetes...

New Drug Target for Promoting Beta Cell Regeneration Discovered

JDRF-funded researchers in collaboration with Hoffmann-La Roche pharmaceutical company have discovered a protein that regulates beta cell growth and a chemical compound that stimulates it. The discovery represents a significant advance in identifying a new drug target for beta cell regeneration...

PositiveID Completes Phase II Testing Of GlucoChip, a Glucose-Sensing Microchip

PositiveID announced it has successfully completed Phase II testing of its GlucoChip™, a glucose-sensing microchip for diabetes patients. In Phase II, the Company, in conjunction with its development partner RECEPTORS LLC, created and demonstrated a stable and reproducible, closed-cycle...

Diamyd Shifts Away from Diabetes To Cut Costs

Diamyd Medical announced it has shifted its focus from the development of the diabetes therapy Diamyd® to the the development of drug candidates for the treatment of chronic pain....